Proinflammatory activity of a cecropin-like antibacterial peptide from Helicobacter pylori

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 6, 2001, Pages 1700-1704

  Bylund, Johan ^a   Christophe, Thierry ^b   Boulay, Francois ^b   Nyström, Thomas ^a   Karlsson, Anna ^a   Dahlgren, Claes ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CEA GRENOBLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CECROPIN; PEPTIDE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CELL SURVIVAL; COMPETITIVE INHIBITION; DRUG EFFECT; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; INFLAMMATORY CELL; PEPTIC ULCER; PRIORITY JOURNAL; RECEPTOR BINDING; STOMACH MUCOSA;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; HELICOBACTER PYLORI; HUMANS; MACROPHAGE-1 ANTIGEN; NADPH OXIDASE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PEPTIDE FRAGMENTS; RECEPTORS, CELL SURFACE; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN;

EID: 0035006334     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.6.1700-1704.2001     Document Type: Article

References (30)

1. Allen, L. A. 2000. Modulating phagocyte activation. The pros and cons of Helicobacter pylori virulence factors. J. Exp. Med. 191:1451-1454.
2. Blaser, M. J. 1993. Helicobacter pylori: microbiology of a 'slow' bacterial infection. Trends Microbiol. 1:255-260.
3. Boman, H. G. 2000. Innate immunity and the normal microflora. Immunol. Rev. 173:5-16.
4. Borregaard, N., and J. B. Cowland. 1997. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503-3521.
5. Boyum, A., D. Lovhaug, L. Tresland, and E. M. Nordlie. 1991. Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality. Scand. J. Immunol. 34:697-712.
6. Chiang, N., I. M. Fierro, K. Gronert, and C. N. Serhan. 2000. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 191:1197-1208.
7. Christophe, T., M. J. Rabiet, M. Tardif, M. D. Milcent, and F. Boulay. 2000. Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells. J. Biol. Chem. 275:1656-1664.
8. Clark, R. A. 1999. Activation of the neutrophil respiratory burst oxidase. J. Infect. Dis. 179(Suppl. 2):S309-S317.
9. Covacci, A., J. L. Telford, G. Del Giudice, J. Parsonnet, and R. Rappuoli. 1999. Helicobacter pylori virulence and genetic geography. Science 284: 1328-1333.
10. Dahlgren, C., T. Christophe, F. Boulay, P. N. Madianos, M. J. Rabiet, and A. Karlsson. 2000. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor. Blood 95:1810-1818.
11. Dahlgren, C., and A. Karlsson. 1999. Respiratory burst in human neutrophils. J. Immunol. Methods 232:3-14.
12. Epand, R. M., and H. J. Vogel. 1999. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1462:11-28.
13. Evans, D. J., Jr., D. G. Evans, T. Takemura, H. Nakano, H. C. Lampert, D. Y. Graham, D. N. Granger, and P. R. Kvietys. 1995. Characterization of a Helicobacter pylori neutrophil-activating protein. Infect. Immun. 63:2213-2220.
14. Feuk-Lagerstedt, E., E. T. Jordan, H. Leffler, C. Dahlgren, and A. Karlsson. 1999. Identification of CD66a and CD66b as the major galectin-3 receptor candidates in human neutrophils. J. Immunol. 163:5592-5598.
15. Fiocca, R., O. Luinetti, L. Villani, A. M. Chiaravalli, C. Capella, and E. Solcia. 1994. Epithelial cytotoxicity, immune responses, and inflammatory components of Helicobacter pylori gastritis. Scand. J. Gastroenterol. Suppl. 205:11-21.
16. 4 receptor. J. Exp. Med. 180:253-260.
17. Halliwell, B. 1994. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344:721-724.
18. Klotz, K. N., K. L. Krotec, J. Gripentrog, and A. J. Jesaitis. 1994. Regulatory interaction of N-formyl peptide chemoattractant receptors with the membrane skeleton in human neutrophils. J. Immunol. 152:801-810.
19. Le, Y., W. Shen, B. Li, W. Gong, N. M. Dunlop, and J. M. Wang. 1999. A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4. Forum (Genoa) 9:299-314.
20. Mai, U. E., G. I. Perez-Perez, J. B. Allen, S. M. Wahl, M. J. Blaser, and P. D. Smith. 1992. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J. Exp. Med. 175:517-525.
21. Murphy, P. M., T. Ozcelik, R. T. Kenney, H. L. Tiffany, D. McDermott, and U. Francke. 1992. A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. J. Biol. Chem. 267:7637-7643.
22. 21a. Putsep, K., C. I. Branden, H. G. Boman, and S. Normark. 1999. Antibacterial peptide from H. pylori. Nature 398:671-672.
23. Rautelin, H., B. Blomberg, H. Fredlund, G. Jarnerot, and D. Danielsson. 1993. Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut 34:599-603.
24. Satin, B., G. Del Giudice, V. Della Bianca, S. Dusi, C. Laudanna, F. Tonello, D. Kelleher, R. Rappuoli, C. Montecucco, and F. Rossi. 2000. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J. Exp. Med. 191:1467-1476.
25. Serrander, L., J. Larsson, H. Lundqvist, M. Lindmark, M. Fallman, C. Dahlgren, and O. Stendahl. 1999. Particles binding beta(2)-integrins mediate intracellular production of oxidative metabolites in human neutrophils independently of phagocytosis. Biochim. Biophys. Acta 1452:133-144.
26. Su, S. B., W. Gong, J. L. Gao, W. Shen, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189:395-402.
27. Uhing, R. J., and R. Snyderman. 1999. Chemoattractant stimulus-response coupling, p. 607-626. In J. I. Gallin and R. Snyderman (ed), Inflammation: basic principles and clinical correlates, 3rd ed. Raven Press, New York, N.Y.
28. West, R. E., Jr., J. Moss, M. Vaughan, T. Liu, and T. Y. Liu. 1985. Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site. J. Biol. Chem. 260:14428-14430.
29. Ye, R. D., and F. Boulay. 1997. Structure and function of leukocyte chemoattractant receptors. Adv. Pharmacol. 39:221-289.
30. Yokomizo, T., T. Izumi, K. Chang, Y. Takuwa, and T. Shimizu. 1997. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387:620-624.